TY - JOUR
T1 - Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
AU - Drug Hypersensitivity Consortium, INCHARGE Consortium
AU - Saper, Vivian E.
AU - Ombrello, Michael J.
AU - Tremoulet, Adriana H.
AU - Montero-Martin, Gonzalo
AU - Prahalad, Sampath
AU - Canna, Scott
AU - Shimizu, Chisato
AU - Deutsch, Gail
AU - Tan, Serena Y.
AU - Remmers, Elaine F.
AU - Monos, Dimitri
AU - Hahn, Timothy
AU - Phadke, Omkar K.
AU - Cassidy, Elaine
AU - Ferguson, Ian
AU - Mallajosyula, Vamsee
AU - Xu, Jianpeng
AU - Rosa Duque, Jaime S.
AU - Chua, Gilbert T.
AU - Ghosh, Debopam
AU - Szymanski, Ann Marie
AU - Rubin, Danielle
AU - Burns, Jane C.
AU - Tian, Lu
AU - Fernandez-Vina, Marcelo A.
AU - Mellins, Elizabeth D.
AU - Hollenbach, Jill A.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2022.
PY - 2022/3
Y1 - 2022/3
N2 - Objectives Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, delayed hypersensitivity reaction (DHR). We observed DRESS to inhibitors of interleukin 1 (IL-1) or IL-6 in a small group of patients with Still’s disease with atypical lung disease. We sought to characterise features of patients with Still’s disease with DRESS compared with drug-tolerant Still’s controls. We analysed human leucocyte antigen (HLA) alleles for association to inhibitor-related DHR, including in a small Kawasaki disease (KD) cohort. Methods In a case/control study, we collected a multicentre series of patients with Still’s disease with features of inhibitor-related DRESS (n=66) and drug-tolerant Still’s controls (n=65). We retrospectively analysed clinical data from all Still’s subjects and typed 94/131 for HLA. European Still’s-DRESS cases were ancestry matched to International Childhood Arthritis Genetics Consortium paediatric Still’s cases (n=550) and compared for HLA allele frequencies. HLA association also was analysed using Still’s-DRESS cases (n=64) compared with drug-tolerant Still’s controls (n=30). KD subjects (n=19) were similarly studied. Results Still’s-DRESS features included eosinophilia (89%), AST-ALT elevation (75%) and non-evanescent rash (95%; 88% involving face). Macrophage activation syndrome during treatment was frequent in Still’s-DRESS (64%) versus drug-tolerant Still’s (3%; p=1.2×10−14). We found striking enrichment for HLA-DRB1*15 haplotypes in Still’s-DRESS cases versus INCHARGE Still’s controls (p=7.5×10-13) and versus self-identified, ancestry-matched Still’s controls (p=6.3×10−10). In the KD cohort, DRB1*15:01 was present only in those with suspected anakinra reactions. Conclusions DRESS-type reactions occur among patients treated with IL-1/IL-6 inhibitors and strongly associate with common HLA-DRB1*15 haplotypes. Consideration of preprescription HLA typing and vigilance for serious reactions to these drugs are warranted.
AB - Objectives Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, delayed hypersensitivity reaction (DHR). We observed DRESS to inhibitors of interleukin 1 (IL-1) or IL-6 in a small group of patients with Still’s disease with atypical lung disease. We sought to characterise features of patients with Still’s disease with DRESS compared with drug-tolerant Still’s controls. We analysed human leucocyte antigen (HLA) alleles for association to inhibitor-related DHR, including in a small Kawasaki disease (KD) cohort. Methods In a case/control study, we collected a multicentre series of patients with Still’s disease with features of inhibitor-related DRESS (n=66) and drug-tolerant Still’s controls (n=65). We retrospectively analysed clinical data from all Still’s subjects and typed 94/131 for HLA. European Still’s-DRESS cases were ancestry matched to International Childhood Arthritis Genetics Consortium paediatric Still’s cases (n=550) and compared for HLA allele frequencies. HLA association also was analysed using Still’s-DRESS cases (n=64) compared with drug-tolerant Still’s controls (n=30). KD subjects (n=19) were similarly studied. Results Still’s-DRESS features included eosinophilia (89%), AST-ALT elevation (75%) and non-evanescent rash (95%; 88% involving face). Macrophage activation syndrome during treatment was frequent in Still’s-DRESS (64%) versus drug-tolerant Still’s (3%; p=1.2×10−14). We found striking enrichment for HLA-DRB1*15 haplotypes in Still’s-DRESS cases versus INCHARGE Still’s controls (p=7.5×10-13) and versus self-identified, ancestry-matched Still’s controls (p=6.3×10−10). In the KD cohort, DRB1*15:01 was present only in those with suspected anakinra reactions. Conclusions DRESS-type reactions occur among patients treated with IL-1/IL-6 inhibitors and strongly associate with common HLA-DRB1*15 haplotypes. Consideration of preprescription HLA typing and vigilance for serious reactions to these drugs are warranted.
UR - http://www.scopus.com/inward/record.url?scp=85122311963&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122311963&partnerID=8YFLogxK
U2 - 10.1136/annrheumdis-2021-220578
DO - 10.1136/annrheumdis-2021-220578
M3 - Article
C2 - 34789453
AN - SCOPUS:85122311963
SN - 0003-4967
VL - 81
SP - 406
EP - 415
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 3
ER -